These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7748621)

  • 1. Dissecting tumourigenesis in transgenic rats.
    Manson M
    Hum Exp Toxicol; 1995 Jan; 14(1):71-2. PubMed ID: 7748621
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
    Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
    Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transgenic rats as a model for investigation of the pathogenesis of hypertension].
    Paul M
    Z Kardiol; 1995; 84 Suppl 4():55-60. PubMed ID: 8585274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
    Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi DF; Asara G; Casabona D; Frau M; Seddaiu MA; Feo F
    Hepatology; 2002 Jun; 35(6):1341-50. PubMed ID: 12029619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transgenic animals in experimental medicine].
    Hermanns W
    Dtsch Tierarztl Wochenschr; 1994 Apr; 101(4):135-41. PubMed ID: 8205963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of mutations in transgenic animal models: BigBlue and Muta Mouse.
    Schmezer P; Eckert C
    IARC Sci Publ; 1999; (146):367-94. PubMed ID: 10353395
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver.
    Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
    Mutat Res; 2005 Aug; 575(1-2):61-84. PubMed ID: 15890375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an enhancer responsible for tumor marker gene expression by means of transgenic rats.
    Suzuki T; Imagawa M; Hirabayashi M; Yuki A; Hisatake K; Nomura K; Kitagawa T; Muramatsu M
    Cancer Res; 1995 Jun; 55(12):2651-5. PubMed ID: 7780980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of the pathogenesis of organ specific autoimmune diseases in transgenic rats carrying the env-pX gene of HTLV-I].
    Fugo K
    Hokkaido Igaku Zasshi; 2001 Sep; 76(5):319-32. PubMed ID: 11593756
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of genetic loci controlling hepatocarcinogenesis on rat chromosomes 7 and 10.
    De Miglio MR; Canzian F; Pascale RM; Simile MM; Muroni MR; Calvisi D; Romeo G; Feo F
    Cancer Res; 1999 Sep; 59(18):4651-7. PubMed ID: 10493520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain.
    De Miglio MR; Simile MM; Muroni MR; Pusceddu S; Calvisi D; Carru A; Seddaiu MA; Daino L; Deiana L; Pascale RM; Feo F
    Mol Carcinog; 1999 May; 25(1):21-9. PubMed ID: 10331741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic disruption of gap junctional intercellular communication enhances early but not late stage hepatocarcinogenesis in the rat.
    Hokaiwado N; Asamoto M; Ogawa K; Shirai T
    Toxicol Pathol; 2005; 33(6):695-701. PubMed ID: 16243774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic animals in medicine: integration and expression of foreign genes, theoretical and applied aspects.
    Goldman IL; Kadulin SG; Razin SV
    Med Sci Monit; 2004 Nov; 10(11):RA274-85. PubMed ID: 15507868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of multistage hepatocarcinogenesis.
    Poole TM; Chiaverotti TA; Carabeo RA; Drinkwater NR
    Prog Clin Biol Res; 1996; 395():33-45. PubMed ID: 8895982
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo cell lineage analysis during chemical hepatocarcinogenesis using retroviral-mediated gene transfer.
    Bralet MP; Calise D; Brechot C; Ferry N
    Lab Invest; 1996 May; 74(5):871-81. PubMed ID: 8642783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of mutant frequencies of chemically induced tumors and normal tissues in lambda/cII transgenic mice.
    Mirsalis JC; Shimon JA; Johnson A; Fairchild D; Kanazawa N; Nguyen T; de Boer J; Glickman B; Winegar RA
    Environ Mol Mutagen; 2005; 45(1):17-35. PubMed ID: 15605353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific chromosomal changes in albumin simian virus 40 T antigen transgenic rat liver neoplasms.
    Sargent LM; Dragan YP; Sattler G; Xu YH; Wiley J; Pitot HC
    Cancer Res; 1997 Aug; 57(16):3451-6. PubMed ID: 9270012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenic chemical-response "fingerprint" for male F344 rats exposed to a series of 195 chemicals: implications for predicting carcinogens with transgenic models.
    Johnson FM
    Environ Mol Mutagen; 1999; 34(4):234-45. PubMed ID: 10618171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter.
    Thompson TA; Haag JD; Lindstrom MJ; Griep AE; Lohse JK; Gould MN
    Oncogene; 2002 Apr; 21(18):2797-804. PubMed ID: 11973638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.